header logo image


Page 5«..4567..1020..»

Archive for the ‘Fat Stem Cells’ Category

Sales Revenue in the Stromal Vascular Fraction Market to Witness Growth at Robust CAGR 4.5% During 2019 to 2029 – Cole of Duty

Wednesday, May 27th, 2020

New York City, United States The change during the COVID-19 pandemic has overhauled our dependence on pattern setting developments, for instance, expanded reality, computer generated reality, and the Healthcare web of things. The unfulfilled cash related targets are persuading the relationship to grasp robotization and forefront advancements to stay ahead in the market competition. Associations are utilizing this open entryway by recognizing step by step operational needs and showing robotization in it to make an automated structure as far as might be feasible.

Stromal vascular fraction is gaining significant importance in various fields, including internal medicine, orthopaedics, plastic and general surgery,and wound healing.

Ease of harvest, abundant availability, and stable phenotype are some factors increasing the demand for stromal vascular fraction. Also, stromal vascular fraction secretes several soluble factors with anti-inflammatory, immunomodulatory, and analgesic effects, which leads to an alternative treatment option for various diseases, significantly benefitting the growth of thestromal vascular fraction marketduring the forecast period.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/20914

Company Profiles

Delivery of stromal vascular fraction by intra-articular injection has advantages over surgical implantation, such as less invasiveness, better patient compliance, and lower cost.

The global stromal vascular fraction market was valued atUS$ 76 Mnin 2018, and is expected to witness a CAGR of around4%over the forecast period (2019-2029).

Key Takeaways of Stromal Vascular Fraction Market Study

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/20914

Stromal vascular fraction has emerged as an efficient alternative in the field of regenerative medication. However, better-structured and significant clinical investigations need to be carried out to demonstrate and define the therapeutic potential of stromal vascular fraction,says a PMR analyst.

Stromal Vascular Fraction Manufacturers Focusing on Innovative Methods to Optimize Tissue Recovery

Consistent up-gradation and innovation in methods to recover adipose tissue-derived mesenchymal stem cells (ATD-MSCs) for autologous use in regenerative medication applications are expected to offer significant opportunities for the stromal vascular fraction market.

For instance, LipoCell from Tissyou, is furnished with a semipermeable film that separates fat tissues from squander components with the assistance of continuous irrigation. The dialysis of the tissue limits the pressure and trauma to the cell and extracellular matrix, evacuating the blood and oil deposits, which are pro-inflammatory.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/20914

More Valuable Insights on Stromal vascular fraction Market

Persistence Market Research brings a comprehensive research report on the forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the segments from 2014 to 2029.

The global stromal vascular fraction market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provide compelling insights on the stromal vascular fraction market on basis of product (SVF isolation products, SVF aspirate purification products, and SVF transfer products), application (cosmetic applications, orthopedic applications, soft tissue applications, and others), and end user (hospitals, ambulatory surgical centers, stem cell laboratories, and others), across six major regions.

What the report encloses for the readers:

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Liquid Chromatographymass Spectroscopy MarketLiquid Chromatography-Mass Spectroscopy Segmented By Triple Quadrupole, Time of Flight, Quadrupole Technology in Clinical Testing, Environmental Testing, Forensic Testing.For More Information

Biopharmaceutical MarketBiopharmaceuticals Market Segmented By Monoclonal Antibodies, Recombinant Proteins, Granulocyte-Colony Stimulating Factor, Interferons, Recombinant Human Insulin, Erythropoietin, Vaccines, Growth Hormones, Purified Proteins Type for Metabolic Disorders, Oncology, Neurological Disorders, Cardiovascular Diseases, Inflammatory and Infectious Diseases.For More Information

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish KoltePersistence Market ResearchAddress 305 Broadway, 7th FloorNew York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Websitehttps://www.persistencemarketresearch.com

View post:
Sales Revenue in the Stromal Vascular Fraction Market to Witness Growth at Robust CAGR 4.5% During 2019 to 2029 - Cole of Duty

Read More...

Global Stem Cell Reconstructive Market- Industry Analysis and Forecast… – Azizsalon News

Monday, May 25th, 2020

Global Stem Cell Reconstructive Marketwas valued US$ XX Mn in 2019 and is expected to reach US$ XX Mn by 2027, at a CAGR of 24.5% during a forecast period.

Market Dynamics

The Research Report gives an in-depth account of the drivers and restraints in the stem cell reconstructive market. Stem cell reconstructive surgery includes the treatment of injured or dented part of body. Stem cells are undifferentiated biological cells, which divide to produce more stem cells. Growing reconstructive surgeries led by the rising number of limbs elimination and implants and accidents are boosting the growth in the stem cell reconstructive market. Additionally, rising number of aged population, number of patients suffering from chronic diseases, and unceasing development in the technology, these are factors which promoting the growth of the stem cell reconstructive market. Stem cell reconstructive is a procedure containing the use of a patients own adipose tissue to rise the fat volume in the area of reconstruction and therefore helping 3Dimentional reconstruction in patients who have experienced a trauma or in a post-surgical event such as a mastectomy or lumpectomy, brain surgery, or reconstructive surgery as a result of an accident or injury. Stem cell reconstructive surgeries are also used in plastic or cosmetic surgeries as well. Stem cell and regenerative therapies gives many opportunities for development in the practice of medicine and the possibility of an array of novel treatment options for patients experiencing a variety of symptoms and conditions. Stem cell therapy, also recognised as regenerative medicine, promotes the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives.

REQUEST FOR FREE SAMPLE REPORT:https://www.maximizemarketresearch.com/request-sample/54666/

The common guarantee of all the undifferentiated embryonic stem cells (ESCs), foetal, amniotic, UCB, and adult stem cell types is their indefinite self-renewal capacity and high multilineage differentiation potential that confer them a primitive and dynamic role throughout the developmental process and the lifespan in adult mammal.However, the high expenditure of stem cell reconstructive surgeries and strict regulatory approvals are restraining the market growth.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Global Stem Cell Reconstructive Market Segment analysis

Based on Cell Type, the embryonic stem cells segment is expected to grow at a CAGR of XX% during the forecast period. Embryonic stem cells (ESCs), derived from the blastocyst stage of early mammalian embryos, are distinguished by their capability to distinguish into any embryonic cell type and by their ability to self-renew. Owing to their plasticity and potentially limitless capacity for self-renewal, embryonic stem cell therapies have been suggested for regenerative medicine and tissue replacement after injury or disease. Additionally, their potential in regenerative medicine, embryonic stem cells provide a possible another source of tissue/organs which serves as a possible solution to the donor shortage dilemma. Researchers have differentiated ESCs into dopamine-producing cells with the hope that these neurons could be used in the treatment of Parkinsons disease. Upsurge occurrence of cardiac and malignant diseases is promoting the segment growth. Rapid developments in this vertical contain protocols for directed differentiation, defined culture systems, demonstration of applications in drug screening, establishment of several disease models, and evaluation of therapeutic potential in treating incurable diseases.

Global Stem Cell Reconstructive Market Regional analysis

The North American region has dominated the market with US$ XX Mn. America accounts for the largest and fastest-growing market of stem cell reconstructive because of the huge patient population and well-built healthcare sector. Americas stem cell reconstructive market is segmented into two major regions such as North America and South America. More than 80% of the market is shared by North America due to the presence of the US and Canada.

DO INQUIRY BEFORE PURCHASING REPORT HERE:https://www.maximizemarketresearch.com/inquiry-before-buying/54666/

Europe accounts for the second-largest market which is followed by the Asia Pacific. Germany and UK account for the major share in the European market due to government support for research and development, well-developed technology and high healthcare expenditure have fuelled the growth of the market. This growing occurrence of cancer and diabetes in America is the main boosting factor for the growth of this market.

The objective of the report is to present a comprehensive analysis of the Global Stem Cell Reconstructive Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Stem Cell Reconstructive Market dynamics, structure by analysing the market segments and projects the Global Stem Cell Reconstructive Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Stem Cell Reconstructive Market make the report investors guide.Scope of the Global Stem Cell Reconstructive Market

Global Stem Cell Reconstructive Market, By Sources

Allogeneic Autologouso Bone Marrowo Adipose Tissueo Blood Syngeneic OtherGlobal Stem Cell Reconstructive Market, By Cell Type

Embryonic Stem Cell Adult Stem CellGlobal Stem Cell Reconstructive Market, By Application

Cancer Diabetes Traumatic Skin Defect Severe Burn OtherGlobal Stem Cell Reconstructive Market, By End-User

Hospitals Research Institute OthersGlobal Stem Cell Reconstructive Market, By Regions

North America Europe Asia-Pacific South America Middle East and Africa (MEA)Key Players operating the Global Stem Cell Reconstructive Market

Osiris Therapeutics NuVasives Cytori Therapeutics Takeda (TiGenix) Cynata Celyad Medi-post Anterogen Molmed Baxter Eleveflow Mesoblast Ltd. Micronit Microfluidics TAKARA BIO INC. Tigenix Capricor Therapeutics Astellas Pharma US, Inc. Pfizer Inc. STEMCELL Technologies Inc.

MAJOR TOC OF THE REPORT

Chapter One: Stem Cell Reconstructive Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Stem Cell Reconstructive Market Competition, by Players

Chapter Four: Global Stem Cell Reconstructive Market Size by Regions

Chapter Five: North America Stem Cell Reconstructive Revenue by Countries

Chapter Six: Europe Stem Cell Reconstructive Revenue by Countries

Chapter Seven: Asia-Pacific Stem Cell Reconstructive Revenue by Countries

Chapter Eight: South America Stem Cell Reconstructive Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Stem Cell Reconstructive by Countries

Chapter Ten: Global Stem Cell Reconstructive Market Segment by Type

Chapter Eleven: Global Stem Cell Reconstructive Market Segment by Application

Chapter Twelve: Global Stem Cell Reconstructive Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Stem Cell Reconstructive Market Report at:https://www.maximizemarketresearch.com/market-report/global-stem-cell-reconstructive-market/54666/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website:www.maximizemarketresearch.com

View original post here:
Global Stem Cell Reconstructive Market- Industry Analysis and Forecast... - Azizsalon News

Read More...

Clinical Trial Shows Topical Stem Cell Treatment Leads to Hair Regrowth in Common Type of Baldness – Technology Networks

Thursday, May 21st, 2020

The results of a new clinical trial published in the journal STEM CELLS Translational Medicine demonstrate how a topical solution made up of stem cells leads to the regrowth of hair for people with a common type of baldness.1

Unfortunately, there are only a few FDA-approved medications to treat hair loss, and these carry a myriad of associated side effects including a negative impact on sexual functioning. There is therefore a pertinent need to develop anti-hair loss treatments that lack such side effects.

Emerging research has demonstrated the potential application of stem cells, particularly adipose tissue-derived stem cells (ADSCs), in this space. ADSCs are a type of mesenchymal stem cell that secrete several growth hormones that facilitate cell development and proliferation.

As previous research has demonstrated that growth factors such as hepatocyte growth factor, vascular endothelial growth factor, insulin-like growth factor and platelet-derived growth factor increase the size of hair follicles during hair development, scientists have explored whether ADSCs can promote hair growth in men and women with alopecia.2,3 The results of such research have been positive, however, a randomized, placebo-controlled trial of such a therapeutic approach in AGA did not exist until now.

"Recent studies have shown that ADSCs promote hair growth in both men and women with alopecia. However, no randomized, placebo-controlled trial in humans has explored the effects and safety of adipose-derived stem cell constituent extract (ADSC-CE) in AGA," says Sang Yeoup Lee, M.D., Ph.D., of the Family Medicine Clinic and Research Institute of Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital. "We aimed to assess the efficacy and tolerability of ADSC-CE in middle-aged patients with AGA in our study, hypothesizing that it is an effective and safe treatment agent."

Participants were instructed to apply 2mL of solution to the area in which they experienced hair loss, twice every day for a total of 16 weeks, massaging the solution into their scalp using their fingers. Each subjected visited the research center four times in total throughout the study, and were requested to keep a diary to record when they were using the solution.

To measure whether the solution was significantly impacting hair growth, the scientists measured changes in total hair number and hair thickness as confirmed by close contract photographs using a standardized technique. This was the primary efficacy variable. Photographs were taken at baseline, eight weeks and 16 weeks after using the product. At baseline, participants received a dot tattoo over their scalp to ensure that the photographs were taken at the same spot at each follow up. The secondary efficacy variables of the study included analysis of global photographs of the participants' scalps by an investigator, and self-evaluation of hair growth by the participants.

Whilst these results are promising, the authors note several limitations to the study. When assessing the secondary efficacy outcomes, the researchers found that the improvement score provided by the investigator was higher in the intervention group than the control, but this was not a significant increase. Additionally, the evaluation provided by the subject was lower in the intervention group. The scientists suggest that a contributing factor here could be the study duration, positing the idea that the length of time in which the participants were involved in the trial may not have been sufficient for them to notice a visual improvement. Furthermore, the self-report assessment could have been limited in validity as subjects may have been impacted by their own expectations towards the intervention. A solution to consider going forward could be to ask participants about their expectations regarding the magnitude of improvement at baseline.

Lee adds, "Our findings suggest that the application of the ADSC-CE topical solution has enormous potential as an alternative therapeutic strategy for hair regrowth in patients with AGA, by increasing both hair density and thickness while maintaining adequate treatment safety. The next step should be to conduct similar studies with large and diverse populations in order to confirm the beneficial effects of ADSC-CE on hair growth and elucidate the mechanisms responsible for the action of ADSC-CE in humans."

"For the millions of people who suffer from male-pattern baldness, this small clinical trial offers hope of a future treatment for hair regrowth," says Anthony Atala, M.D., Editor-in-Chief ofSTEM CELLS Translational Medicineand director of the Wake Forest Institute for Regenerative Medicine. "The topical solution created from proteins secreted by stem cells found in fat tissue proves to be both safe and effective. We look forward to further findings that support this work."

References:

1. Tak, Lee, Cho and Kim. (2020). A randomized, doubleblind, vehiclecontrolled clinical study of hair regeneration using adiposederived stem cell constituent extract in androgenetic alopecia. Stem Cells Translational Medicine. DOI: https://doi.org/10.1002/sctm.19-0410.

2. Ramdasi S, Tiwari SK. (2016). Growth factors and cytokines secreted in conditioned media by mesenchymal stem cells-promising possible therapeutic approach for hair regeneration. J Stem Cells. https://www.ncbi.nlm.nih.gov/pubmed/28296872.

3. Lee et al. (2001). Hepatocyte growth factor (HGF) activator expressed in hair follicles is involved in in vitro HGF-dependent hair follicle elongation. J Dermatol Sci. 25:156-163.

Read the original post:
Clinical Trial Shows Topical Stem Cell Treatment Leads to Hair Regrowth in Common Type of Baldness - Technology Networks

Read More...

This Food Tech Startup Is Replacing Animal Fats With Plants – LIVEKINDLY

Thursday, May 21st, 2020

CUBIQ Foods is aiming to replace animal-based fats with vegan and cultured ingredients.

Founded in 2018 by Dr. Raquel Revilla and Andrs Montefeltro, the Barcelona-based food tech startup promotes sustainability, human health, and animal welfare.

One of the companys products, the vegan SMART FAT, enhances the flavor of low-fat vegetable, animal, or cultivated proteins. It contains less saturated fat and fewer calories than traditional emulsions and uses 100 percent sustainable ingredients. SMART FAT is designed to replace unhealthy fats in meat, dairy, flexitarian, and vegan products.

CUBIQ also produces vegan-friendly SMART Omega-3, which carries a concentrated and encapsulated form of the polyunsaturated fatty acid.

The highly concentrated essential oils maintain their properties for use within even the most demanding industrial recipes. This can assist food producers to include recommended daily amounts of omega-3 in affordable and healthy products.

Sustainable omega-3 and vegan healthier fats inspire our team and partners, said Montefeltro. We are ready to deliver a new generation of nutritious, healthy, and accessible products at an industrial scale by the end of this year.

The company just received 5 million in funding from Blue Horizon Ventures and Moira Capital Partners SGEIC.

This new wave of funding will help CUBIQ produce its sustainable fats on an industrial scale, ready to launch at the end of 2020. The company is the first of its kind to produce such products on this scale. It is also the first cultivated fat cell platform to produce such high-quality omega-3s in this way.

CUBIQ Foods also uses cultured fat to produce oil-enriched omega-3.

In an email sent to LIVEKINDLY, Montefeltro explained that the company uses duck stem cells to produce DHA and EPA enriched oils. Montefeltro said the process is more sustainable than fish oil, a traditional source of omega-3.

Proponents of lab-grown food believe that growing ingredients from cell culture can be less resource-intensive than traditional methods. Cultivated animal products can provide a low-impact and clean alternative to conventional animal agriculture.

Traditional animal agriculture is responsible for 14.5 percent of global greenhouse gas emissions globally.The production of food from cell culture, in the form of tissue, will undoubtedly be the most efficient and scalable way to meet the food needs we will face in the coming years, said Montefeltro.

Summary

Article Name

This Food Tech Startup Is Replacing Animal Fats With Plants

Description

Barcelona-based CUBIQ Foods produces sustainable, healthy food ingredients, including vegan and cultured fat and concentrated omega-3.

Author

Liam Pritchett

Publisher Name

LIVEKINDLY

Publisher Logo

Read the original post:
This Food Tech Startup Is Replacing Animal Fats With Plants - LIVEKINDLY

Read More...

Accelerating the cultured meat revolution – New Scientist

Thursday, May 21st, 2020

It will be made in a similar way to brewing beer, says Lavanya Anandan. She is not talking about a new kind of drink, however, but describing a new industry aiming to grow meat in the lab. This new food is known as clean meat, cultured meat or cultivated meat.

Demand for meat has never been higher, but the way we produce it today is unsustainable and, for some, ethically dubious. So scientists around the world are learning to grow meat and seafood in their labs without the need for farms or livestock.

They have had considerable success the worlds first lab-grown beef burger was cooked and tasted in London in 2013, albeit at a price of around $250,000 and costs have dropped by orders of magnitude since. The challenge now is to turn these lab-based successes into food that can be sold on supermarket shelves at reasonable prices.

Thats how Anandan fits in. Leading a new Innovation Field on this topic and based in Silicon Valley, Anandan works for Merck KGaA, Darmstadt, Germany, a leading science and technology company in Healthcare, Life Science and Performance Materials with a 350-year record of innovation. The companys strategy and transformation team is working on new products and technologies for the future. One of their goals is to provide the technology platforms and infrastructure that will enable the cultured meat revolution.

Advertisement

This revolution is desperately needed. The worlds population is growing, with another 2 billion expected by 2050. Demand for meat is expected to grow by 70 per cent, significantly increasing the pressure on limited resources such as land and water. This in turn will drive climate change. Today, livestock farming is responsible for 15 per cent of global greenhouse gas emissions and is a key cause of deforestation. If you look at the numbers, theyre quite staggering, says Anandan.

If meat could be grown in the lab instead of on farms, it could create an alternative to traditionally-produced meat and help reduce the environmental footprint for meat production. Additionally, by reducing or eliminating the use of antibiotics and hormones, cultured meat could also have positive health aspects.

Cultured meat is produced using some of the same technologies biologists have used for decades to grow animal cells. First, muscle cells are taken from live animals as a small biopsy from which stem cells are isolated and then cultured in the lab.

The next stage is more difficult, however. The cultured cells must then be grown and differentiated into a form of tissue comprising of muscle, fat and other cells that is suitable for food processing and consumption. This takes place inside bioreactors where the cells are trapped and supported in a scaffold of fibres, just as in animal tissue, and submerged in a cocktail of nutrients called a growth media. Finally, this tissue must be processed and formed into products such as burgers patties, sausages or shrimp mince.

Currently, around 60 start-ups around the world are developing and improving the cultured meat process to make different meats and seafood. Most of them are growing its own special cells that require bespoke growth media and cellular scaffolding. And they are all looking to scale up production while bringing down costs.

This is where the expertise of Merck KGaA, Darmstadt, Germany, comes in. The techniques used to culture meat are the same for the biologics and cell therapy industry and, as a leading life sciences company, weve helped solve similar challenges, says Anandan.

The company is not aiming to grow its own meat but to develop the materials and technologies that will accelerate its development. And it is already working with start-ups, non-profits and academics. We are taking our existing expertise and trying to come up with innovative solutions and technologies such as reagents and analytical tools to solve problems for the clean meat sector, she says.

One important goal is to find the right formulation for the growth media. This is a cocktail of 50 to 100 ingredients such as sugars, salts, amino acids, micronutrients and growth factor. Each cell line is going to require a specific optimised formula, says Anandan.

This growth medium must also not contain animal-derived compounds and economical enough to make lab-grown meat affordable. Cost is an important hurdle that has to be overcome, she says. Currently, culture media costs hundreds of dollars per litre, but for clean meat production to scale this needs to drop to around $1 a litre.

Other challenges for the industry are to develop the tissue scaffolds needed to support growth of the cells, and to engineer the specialised bioreactors needed to scale-up production.

So when will the fruits of this cellular agriculture reach the supermarket shelves? In the next few years we can expect a few launches of small-scale products in high end restaurants. It will be a pretty expensive burger in a restaurant in Hong Kong or San Francisco says Anandan. My prediction is that by 2030 you might see them on supermarket shelves at a decent price.

To find out more:In the US, click hereIn the UK, Europe and RoW, click here

Free online eventThe global demand for meat is expected to rise nearly 70% by 2050. Cultured Meat could help to feed this growing hunger for animal protein with less negative impact on the environment. But which technology hurdles do scientists have to overcome before cultured meat becomes mainstream?When: 10 June 2020, from 16:30 to 17:30 BSTWhere: onlineIn the US, register for free hereIn the UK, Europe and RoW, register for free here

What if medicines could be 3D printed? Or plants grown in agricultural tunnels using nanotechnology that fine-tunes sunlight to boost yields? Or cultured meat grown in bioreactors? These ideas have the potential to transform industries but they need a helping hand to come to fruition. This is exactly the aim of the Innovation Centers of Merck KGaA, Darmstadt, Germany.

The Innovation Center is a playground for scientists and entrepreneurs to explore new fields and develop new businesses beyond the companys current scope. These teams are now operating at the companys headquarters in Darmstadt, Germany, with additional hubs in Silicon Valley and China, with involvement from colleagues around the world. Our innovation projects operate like startups, says Lavanya Anandan, who is coordinating the clean meat innovation field at the California site. The Innovation Center and Innovation Hubs are building an ecosystem where we can grow viable new businesses with the backing and know-how of a big company.

In addition to the clean meat research, the Innovation Center is working on a laser-adjustable lens replacements for people with cataracts, new technologies for structure analysis on a sub-microgram scale and many other challenges.

Find out more.In the US, go to: innovationcenter.emdgroup.comIn the UK, Europe and RoW go to: innovationcenter.merckgroup.com

Read the original post:
Accelerating the cultured meat revolution - New Scientist

Read More...

BUSINESS: Can lab-grown meat save the planet and dinner? – E&E News

Thursday, May 21st, 2020

The idea is hard to stomach at first: animal meat grown in a lab.

But proponents of "cell-based meat" say the emerging technology has the potential to tackle two global problems at once. Lab-grown beef patties, chicken cutlets and even exotic proteins could help satisfy the world's growing appetite for meat, they argue. And it could be done in a way that cuts down on the tremendous environmental impact of animal agriculture.

Standing in the way is a long list of challenges including regulatory obstacles, sky-high production costs and the ever-present ick factor.

Still, advocates say lab-grown meat could hit store shelves as soon as 2025 if not earlier.

One proponent is Krijn de Nood, the chief executive of Meatable, a Netherlands-based company that is producing animal tissue by mimicking the cellular growth that typically happens inside rather than outside of living organisms. In an interview, de Nood said Meatable is "mission driven" and that it aims to address issues from climate change to animal welfare.

Advertisement

The company is among dozens of startups worldwide that are racing to scale technology they claim produces "real meat" not plant-based alternatives from companies such as Impossible Foods and Beyond Meat (Climatewire, Oct. 21, 2019).

That's possible, they say, because most cultured protein products originate as stem cells from real animals. Some companies make a point to say that no animals are harmed in the process.

Here's how it typically works. Engineers obtain an animal stem cell sample and isolate "cell lines" with the strongest genetic material. The cells are then placed in an environment like a petri dish or bioreactor that encourages rapid growth, and later differentiation. The resulting fat and muscle tissue is then harvested, structured and processed to create a final product.

De Nood said Meatable already has produced small quantities of meat using this process. And the whole thing took just three weeks a far faster timeline, Meatable notes, than it takes to raise an animal for slaughter. The company plans to host its first public taste testing of a pork prototype in September.

Several other companies already have allowed outsiders to sample their products. Those include Memphis Meats, Peace of Meat and Mosa Meat, which are based in the U.S., Belgium and the Netherlands, respectively.

In fact, one of the first cultured meat tastings dates back to 2013, when Maastricht University physiologist Mark Post presented the world with a beef patty that was produced in a petri dish.

At the time, that single slab of meat cost a whopping 250,000 to produce; Google co-founder Sergey Brin picked up the tab. Several years later, Post co-founded Mosa Meat.

More recently, in March, Peace of Meat hosted an event where attendees sampled a chicken nugget.

Tasting aside, co-founder David Brandes underscored that the startup has a different ambition than many other companies. Rather than producing consumer-facing products, Peace of Meat aims to eventually grow more than 100,000 tons of pure, cultured fat per year. The startup plans to sell the fat to other companies as a key ingredient to enhance the taste and texture of alternative meat products, including those that are plant-based.

"We don't want to make the most fancy-looking piece of food, we don't want to work on exotic species," said Brandes. "You need to produce massive amounts of meat if you really want to have an impact."

Animal agriculture is responsible for a whopping 14.5% of planet-warming emissions, according to the Food and Agriculture Organization of the United Nations. That figure includes greenhouse gases attributable to meat processing, meat-related transportation and manure storage. Then there's the issue of belching cattle which itself is responsible for 65% of the livestock sector's emissions.

Paul Mozdziak, who serves as Peace of Meat's chief scientific officer, was among those who said a central goal of cellular agriculture is to satisfy the world's staggering, and still rising, demand for animal protein but without relying on supply chains that scientists say are environmentally fraught and highly vulnerable to marketplace disruptions.

As an example, Mozdziak pointed to the novel coronavirus crisis, which in recent weeks has temporarily shuttered meat packing plants, forced farmers to cull tens of thousands of animals and spurred fears of a nationwide protein shortage (Greenwire, May 4).

"I absolutely think the pandemic supports the need for this," said Mozdziak, who also directs North Carolina State University's graduate physiology program.

"It's another way to produce food. It's another way to produce protein. It's another way to increase food security," he added. "What if something [else] happens? ... [W]here's the protein going to come from? How are we going to eat?"

But even Mozdziak, who has pondered cultured meat since the early 1990s, acknowledged the obstacles ahead. Despite entrepreneurs' ambitions, he said, the field remains deep in research and development and far from supermarket shelves.

De Nood, of Meatable, highlighted that same issue. "It's all about the scalability of the process," he said, noting that his company is working to drive down costs and move its operations from "small environments" to large bioreactors that would require major processing factories.

Peace of Meat's Brandes agreed. But he said that even if production costs fall, there's the possibility that cultured meat would not meaningfully impact the carbon footprint of the global food system.

"When it comes to greenhouse gas emissions, I think there is a big potential," said Brandes. But producing large quantities of cultured meat would inevitably require substantial amounts of energy, too, "so it really depends where you draw the energy from," Brandes said.

Despite those obstacles and more, some projections have named cultured meat as a key driver of a revolutionary shift away from animal agriculture. Independent think tank RethinkX, for instance, predicts that cell-based meat and plant-based alternatives could render industrial cow farming "obsolete" in the U.S. entirely.

Ermias Kebreab, who is a climate and animal agriculture expert at the University of California, Davis, disagreed with that assessment.

Even as the world becomes more invested in exploring alternatives to conventional protein, Kebreab said, researchers and traditional farmers are actively developing strategies like feeding seaweed to cows to cut the sector's environmental footprint.

In his eyes, sustainable agriculture, rather than cellular agriculture, is what will ultimately enhance food security in developing countries where most future population growth is predicted to occur.

"I'd rather have beef" from cows, said Kebreab, adding that cell-based meat also raises other issues for him, like the products' overall nutritional value. He said he's wary of "highly, highly processed food."

Mozdziak, of Peace of Meat, agreed in part. He doesn't see cellular agriculture putting meat companies out of business.

But "at the same time," he said, "let me vehemently state that I think cultured meat is really important. ... [I]f we're going to have a billion more people on the planet in 30 years, we're going to have to find a way to feed them."

Follow this link:
BUSINESS: Can lab-grown meat save the planet and dinner? - E&E News

Read More...

Business development of Vita 34 stable and unaffected by COVID-19 development so far – PharmiWeb.com

Thursday, May 14th, 2020

DGAP-News: Vita 34 AG / Key word(s): Quarter Results14.05.2020 / 07:30 The issuer is solely responsible for the content of this announcement.

Business development of Vita 34 stable and unaffected by COVID-19 development so far

Leipzig, 14 May 2020 - Vita 34 AG (ISIN: DE000A0BL849; WKN: A0BL84), one of the largest cell banks in Europe, has made a stable start to the new 2020 financial year. Revenues in the first quarter remained almost at the previous year's level. In the second quarter, the current order intake also shows a linear sales development so far. To secure the supply of production-relevant preliminary products, sufficient precautions have been taken to prevent negative effects on process stability in connection with the COVID-19 pandemic.

At EUR 4.7 million, revenues in the first quarter were 2.3 percent below the previous year (Q1 2019: EUR 4.8 million). As a result of the targeted increase in marketing and sales expenses by approximately nine percent to EUR 1.4 million compared to the prior-year period (Q1 2019: EUR 1.3 million), earnings before interest, taxes, depreciation and amortization (EBITDA) were down 9.9 percent to EUR 1.2 million (Q1 2019: EUR 1.3 million). "In the past financial year we analyzed how to deploy our budgets in an even more targeted manner in order to achieve organic growth in our core market," explains Dr. Wolfgang Knirsch, CEO of Vita 34 AG. "Accordingly, we have increased our marketing and sales expenses in certain areas in order to accelerate our organic growth and further consolidate our leading market position."

The company's liquidity situation remains very positive. At EUR 9.1 million, cash and cash equivalents were at the same level as at the end of 2019 (31.12.2019: EUR 9.1 million). "The changed environment, which came as a surprise to us with the COVID-19 pandemic in the first quarter of 2020, required extraordinary efforts at all levels. Due to the still difficult assessable range of the effects of the pandemic, the focus of the measures was on maintaining core processes. From today's perspective, we have achieved this. It is therefore all the more pleasing that despite the expansion of working capital that was necessary in certain areas, liquidity was maintained at a high level," explains Falk Neukirch, CFO of Vita 34 AG.

The key figures for business development in the first quarter of 2020 are as follows:

Since the beginning of May, the company has also been able to return to addressing the relevant target groups personally in the market. "It goes without saying that we are exercising the utmost caution in dealing with this special situation," explains CFO Falk Neukirch. "As things stand at present, however, we are making good progress through these challenging times."

According to Chinese scientists, it should be possible to successfully treat critical COVID-19 pneumonia with the help of connective tissue stem cells, so-called mesenchymal stem cells from umbilical cord tissue. Since these cells are chemotactic, they migrate specifically to sites of inflammation, trigger regeneration processes and weaken the inflammatory reaction. This approach has now been taken up and positively evaluated in a specialist publication of the Harvard Medical School. This supportive therapy is currently being investigated in 19 clinical studies in Asia and Europe. "The results of most of these studies will not be available until later this year", explains CEO Dr. Wolfgang Knirsch, "If the results are positive, we expect that the regenerative potential of stem cells from umbilical cord blood and umbilical cord tissue will again receive increased attention".

Against the background of the stable business development in the first quarter and the previous indication for the second quarter, the Management Board of Vita 34 continues to adhere to its forecasts for the financial year 2020.

Contact:Ingo MiddelmenneInvestor RelationsVita 34 AGPhone: +49 (0341) 48792 - 0Mobile: +49 (0174) 9091190Email: ingo.middelmenne@vita34.de

Company ProfileVita 34 was founded in Leipzig in 1997 and is today one of the leading cell banks in Europe. As the first private umbilical cord blood bank in Europe and a pioneer in cell banking, the company has since then been a complete provider of cryopreservation services for the collection, processing and storage of stem cells from umbilical cord blood and umbilical cord tissue. Based on the expansion of the business model in 2019, Vita 34 intends to also offer the storage of immune cells from peripheral blood as well as of stem cells from endogenous fat in the future. Nursing cells are a valuable source of medical cell therapy and are kept alive at temperatures as low as minus 200 degrees Celsius to be used as part of a treatment when needed. More than 237,000 customers from more than 20 countries have already provided for their family's health with a cell depot at Vita 34.

14.05.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at http://www.dgap.de

View post:
Business development of Vita 34 stable and unaffected by COVID-19 development so far - PharmiWeb.com

Read More...

Doctors Say Inflammation Might be the Root of COVID-19 Along with Other Diseases Such as Cancer and Dementia – Tech Times

Tuesday, May 12th, 2020

Studies show that COVID-19, cancer, Alzheimer's, heart disease, and diabetes have one common factor and root: inflammation. This is now a key factor in many other diseases that have been emerging recently, and it's a process that everybody needs to understand and study more if we want to try and reduce risks.

This root has been identified as a major problem in COVID-19 cases, which explains why older people and those who have lifestyle diseases are most at high risk.

(Photo : Screenshot from: Pexels Official Website)

Read Also: COVID-19 UPDATE: Stem Cell Clinics Offer Unproven "Immunity Booster" for COVID-19 Without Any Proof It Works, You Have Been Warned

For scientists and medical experts, inflammation is a huge clue to what lies beneath the huge number of coronavirus deaths in the United Kingdom now total 32,065 compared to Spain's 26,744, and Italy's 30,560. These numbers reflect the seriousness of the underlying chronic disease.

However, doctors are hopeful that knowledge gained from studying COVID-19 will help us further understand inflammatory processes and suggest different ways to approach this pandemic that has plagued millions of people all over the world.

When we talk about inflammation, this is a sign of the human body's natural response to an infection. When the immune system is mobilized, activity by the defensive cells causes by-products like skin redness and heat or even a fever to occur when the entire system is involved.

Read Also: COVID-19 U.K. Update: People Who Have Low Paying Jobs Are More Likely To Get Infected And Have Died More From COVID-19, Analysis States

However, it should also be noted that obesity and chronic disease can cause inflammation as well.

According to Daily Mail, "Overweight people - almost two out of three Britons fall into this group - have been shown to have higher levels of inflammatory messenger molecules called cytokines, which interfere with and damage normal cell functions. A major research review, published in 2016 by the American Society for Nutrition, concluded that obesity and the health problems associated with it - such as high blood pressure, raised blood sugar levels and tummy fat - have a 'substantial impact' on the health of the immune system and defense against disease."

Research that was published last week by an Oxford University team that identified and analyzed health records from more than 17.4 million people, has calculated that the most severely obese and overweight people are three times more likely to suffer and die of coronavirus.

The body's immune system has a total of two lines of defense, innate immunity, which includes cell types that are on the lookout for foreign fungus, bacteria, and viruses. The second line is something that is more unique to each person that has developed over time to identify and destroy any kind of invader that has tried to invade our body in the past.

"The problem is that innate immunity starts to deteriorate from the age of about 50 and goes into a steep decline from 70. Adaptive immunity also starts to fail, with specialist antibody cells 'forgetting' to recognize the invaders they are meant to protect against. This malfunction occurs even in otherwise healthy older people, and the immune system tries to compensate for the deficit by over-producing cytokines, which buzz about looking for trouble - but in doing so cause inflammation," The Daily Mail added.

A spokesperson for the World Cancer Research Fund, Kate Allen, said that having a healthy weight is very critical in trying to reduce risks from cancer.

Fifteen of the most common cancers, which include colon, prostate, and breast are more common in people who are overweight caused by the inflammation.

Read Also: After Making a "Low Risk" Contact with COVID-19 Tests Positive White House Staffer, Dr. Anthony Fauci Will Begin Modified Quarantine

2018 TECHTIMES.com All rights reserved. Do not reproduce without permission.

More:
Doctors Say Inflammation Might be the Root of COVID-19 Along with Other Diseases Such as Cancer and Dementia - Tech Times

Read More...

Researchers discover stem cells’ ‘death-defying’ quality that aids healing – ETHealthworld.com

Sunday, May 10th, 2020

Washington D.C: Already known for their shape-shifting abilities, stem cells can now add "death-defying" to their list of remarkable qualities, suggests a novel study.

The new study shows how stem cells, which can contribute to creating many parts of the body, not just one organ or body part, are able to postpone their own death in order to respond to an injury that needs their attention.

The study was done in planarians, which are tiny worms used as model organisms to study regeneration because of their ability to recover from any injury using stem cells.

"Planarian stem cells, even when challenged and under a lot of duress, will still respond to an injury by delaying death," said Divya Shiroor, first author and a graduate student in Dr Carolyn Adler's lab, in the College of Veterinary Medicine.

This could have important implications for cancer research and therapies, particularly when examining chemotherapy and surgery options for patients.

"By understanding how injury prompts planarian stem cells to withstand radiation. We hope to identify genes that, if shared with mammals, could perhaps help hone existing therapies," Shiroor said.

Planarians are commonly used in basic research because of their similarities to humans. Like humans, planarians have stem cells, similar organs and similar genes, but are much more adept at responding to injury, thanks to their higher volume of stem cells and lack of a developed immune system, which in humans complicates the healing process.

"This really simplifies the process of understanding the effects of both injury and radiation on stem cells, and allows us to study it directly without being hampered by parallel processes integral to wound healing, such as inflammation, that get simultaneously triggered in mammals," Shiroor said.

By uncovering the mechanisms that govern stem cells after wounding in a system like planarians, researchers could also apply this knowledge when engineering stem cells to respond similarly in the human body.

Labs have many ways to understand how planarians use stem cells to successfully recover and regenerate, but the Adler lab's combination of radiation and injury to identify a novel stem cell response is unique. The researchers plan on digging deeper to understand how the stressed stem cells know that there is an injury and what role other cells may play in their response.

"We have identified a key gene that is required for stem cell persistence after radiation and injury. and we plan on using this as a stepping stone for further exploration," Shiroor said.

Read more:
Researchers discover stem cells' 'death-defying' quality that aids healing - ETHealthworld.com

Read More...

What science says about the benefits of fasting and its spiritual value – TRT World

Sunday, May 3rd, 2020

Fasting is a deeply spiritual experience sanctioned by the Islamic faith, but medical experts also point out neurological and nutritional benefits for the human body and brain.

For centuries, Ramadan, the Islamic holy month in which the faithful fasts from sunrise to sunset, brings a lot of joy to Muslims worldwide.

Dating back to the 7th Century, scientific evidence suggests that the month of fasting has health benefits, which is much needed at this time amid the deadly pandemic.

If an individual cares about having a regular sleep, a regular nutrition and other regular movements of life, he/she will capitalise on the benefits of fasting in Ramadan more than others, said Murat Alemdar, an associate professor of neurology at the Medical School of the Sakarya University.

But for people with erratic lifestyles and sleep and nutritional disorders, they will have a limited benefit package from Ramadans fasting, Alemdar says.

Alemdar has conducted extensive research on how fasting affects the activities of the human brain, concluding that it offers major benefits for people to conduct a healthier life.

Ramadan: A helping hand to the brain

Since ancient times, scientists from different faiths and backgrounds have long argued that fasting could help metabolism renew itself, triggering a detoxification process in the human body.

This reform process could be even more true for the functions of the human brain as fasting could lead to the release of the brain-derived neurotrophic factor (BDNF), which is crucial to produce stem cells.

These cells are the essential units of human metabolism working pretty much as the bodys repair department with their potential to regenerate and repair damaged tissue. They also produce new white blood cells, empowering the immune system against the bodys external enemies.

There are links between fasting and increasing levels of secretion in the BDNF activity, augmenting the production of brain stem cells, Alemdar told TRT World, saying that more brain cells will also help the centre of the nervous system function better.

Fasting also helps the brain rest in a period when other organs of the human body such as the stomach are less in use because eating, drinking, smoking and other related activities come to a halt in Ramadan, according to Alemdar.

In a period, when less nutrition enters the human body, leading to other organs to send much less signals to the brain [where more than 100 billion nerves communicate with each other constantly to ensure the body to function in a proper sense] and help it rest a little more than other times, Alemdar said.

In a spiritual sense, the brain also rejoices when the nervous system believes that something important for life has been fulfilled by fasting, Alemdar says.

Its known that feeling peace due to a fulfilled mission in a field of worshipping brings tranquility, creating positive effects in the human brain, Alemdar underlined.

Increasing mental focus

Ramadans mental focus also helps the brain function better because fasting is not just about making a halt on nutrition habits and sexual activities but also about staying away from negative thinking and reimagining our life, relations and family matters in a spiritual way, according to experts.

Fasting liberates the brain from many other daily activities, increasing the prospects of its concentration on essential functions in the nervous system, Alemdar observed, citing reduced anxiety in Ramadan.

But he also advises that fasting by itself is not a free-ride for mental health and its stabilisation, urging people to plan their time carefully between iftar, when fasting ends with an evening meal, and sahur, a pre-dawn meal, after which fasting begins.

We need to standardise both our sleeping and nutrition patterns between iftar and sahur. If our body is accustomed to a good Ramadan routine, it could help our brain function better, Alemdar suggests.

In Ramadan, Muslims wake up at midnight for sahur to eat and as a result, their sleep is divided. But it shouldnt mean sleep deprivation, Alemdar says, strongly advising people to stick with their regular sleeping hours even in Ramadan.

People might take Qailulah as Muslims call it, or siesta sleep as others call it, which is a short midday nap, relieving the brain for the implementation of its functions, Alemdar suggests, reminding that sleep is essential as much as food.

Beyond the brain, fasting also helps other organs of the human body.

Fasting and its benefits for good nutrition

Fasting also improves the digestive system because the body will have a rare opportunity year-around to detoxify internal organs as the spiritually-alleviating dieting forces the body to use fat reserves to keep operating in the absence of nutrition, killing harmful toxins stored in fat deposits in the process.

In our daily lives, because we consume so much food, our body spends a lot of time digesting them. During fasting, the digestive system works less, allowing the body to focus on other areas like strengthening the immune system and diminishing the levels of infections, says Ceren Kucukvardar, a Turkish nutritionist.

Fasting can also help the body fight conditions like oxidative stress, which can increase the possibility of cancer, slowing the speed of the spread of cancer cells, Kucukvardar observes.

But for many nutritionists, the most important gain of fasting could be weight loss, according to Kucukvardar.

When you take less food, it means you also decrease the levels of insulin, [a hormone, which controls the amount of sugar in the blood], reducing fat, Kucukvardar told TRT World.

For people who observe Ramadan, the conditions of their liver also improve significantly as fasting decreases its fat, Kucukvardar says.

According to various studies, fasting helps people lower their LDL cholesterol and reduce their excessive fatty tissue, decreasing the possibility of heart-related diseases and strokes.

We have a hormone in our body called adiponectin, which is important both protecting our heart health and keeping our glucose levels low. According to some studies, fasting increases this hormone, says Kucukvardar.

As a result, we can say that fasting protects the health of our heart, Kucukvardar says.

But she also warns that fasting people need to be careful about their eating habits during Ramadan.

If we have too much food intake during iftar, it could lead to stomach and intestine diseases, she cautions, suggesting thatiftarshould be divided into two different periods.

First, eat low-calorie foods like soup and cheese and then have a break like 15 minutes. After that, move to the main course, she advises.

Source: TRT World

More here:
What science says about the benefits of fasting and its spiritual value - TRT World

Read More...

How to make sure you are getting enough vitamins: foods, supplements and everything you need to know – The National

Tuesday, April 21st, 2020

Our lifestyles have changed dramatically in recent weeks. As we all do our bit to stem the spread of Covid-19 by staying at home, our sleeping, eating and working patterns have been thrown into disarray. Most of us are moving less, getting less access to fresh air and less exposure to sunlight.

This may mean that our bodies are not receiving the essential minerals and vitamins they need. And getting the right balance of nutrients is essential to keeping our bodies functioning properly all the more important when we are all trying to ensure our immune systems are strong.

Vitamin D, in particular, might be a problem at the moment, as the body relies on sunlight to produce it. People currently isolating in apartments, with no access to outside space, need to be conscious of a potential deficiency.

Vitamin D is known as the sunshine vitamin, since it is made by the body after being in the sun. Vitamin D helps the body absorb calcium. You need calcium for the normal development and maintenance of healthy teeth and bones. It also helps maintain proper blood levels of calcium and phosphorus. Ten to 15 minutes of sunshine, three times a week, is enough to produce the body's requirement of vitamin D for most people at most latitudes, explains Dr. Nadine Aoun, clinical dietician at Medcare.

Try to eat a wide variety of colourful vegetables every day and follow a balanced diet

While it is difficult to get enough vitamin D from food sources alone, Dr Mariam Khalfan Al Suwaidi, head of Healthpoints department of dermatology, highlights some foods that can help. Foods high in vitamin D include oily fish, mushrooms, eggs and dairy products, and vitamin-D-fortified foods. Also try to eat a wide variety of colourful vegetables every day and follow a balanced diet to ensure you get all vitamins and minerals.

Given the importance of Vitamin D, and the struggles that many people have getting it in sufficient quantities, particularly under the current circumstances, Natasha Rudatsenko, founder of the online health and fitness platform, Health Nag, recommends taking a supplement.

It is absolutely essential, she says. Vitamin D contributes a lot to our overall immunity as well as hormonal balance, so this is something I recommend taking for absolutely everyone. 5,000 to 7,000 IU is a good daily dose. Go for its active form, the one that is most bioavailable to our body, Vitamin D3. Its a fat-soluble vitamin, so it is good to take it with something fatty. The most convenient way of getting vitamins, in my opinion, is still http://www.Iherb.com."

As a general consensus, medical experts recommend that you do not overdo the vitamin supplements. With some vitamins, too much can be as harmful as too little. The aim is to try to achieve a balanced and healthy diet, before you go reaching for the supplements.

Dr Aoun offers a breakdown of the vitamins you need, and some of the foods you should be consuming to get them:

Vitamin A: Helps form and maintain healthy teeth, bones, soft tissue, mucus membranes and skin. Found in beef, liver, eggs, shrimp, fish, fortified milk, sweet potatoes, carrots, pumpkins, spinach and mangoes.

Vitamin B6: Helps form red blood cells and maintain brain function. It also plays an important role in the proteins that are part of many chemical reactions in the body. Found in meat, fish, poultry, legumes, tofu and other soy products, and bananas.

Vitamin B12: Like the other B vitamins, this is important for metabolism. It also helps form red blood cells and maintain the central nervous system. Found in meat, poultry, fish, milk, cheese, fortified soy milk and cereals.

Vitamin C: An antioxidant that promotes healthy teeth and gums. It helps the body absorb iron and maintain healthy tissue. It is also essential for wound healing. Found in citrus fruit, potatoes, broccoli, bell peppers, spinach, strawberries, tomatoes and Brussels sprouts.

Vitamin E: Also an antioxidant. It helps the body form red blood cells and use vitamin K. Found in vegetables oils, leafy green vegetables, whole grains and nuts.

Vitamin K: Without this, blood would not stick coagulate. Found in spinach, broccoli and kale.

Biotin (B7): Essential for the metabolism of proteins and carbohydrates, and in the production of hormones and cholesterol. Found in whole grains, eggs, soy beans and fish.

Niacin (B3): A B vitamin that helps maintain healthy skin and nerves. Found in meat, poultry, fish, fortified and whole grains, mushrooms and potatoes.

Folate: Works with vitamin B12 to help form red blood cells. It is needed for the production of DNA, which controls tissue growth and cell function. Found in fortified grains and cereals, asparagus, spinach, broccoli, legumes (black-eyed peas and chickpeas) and orange juice.

Pantothenic acid: Essential for the metabolism of food. Found in chicken, whole grains, broccoli, avocados and mushrooms.

Riboflavin (vitamin B2): Important for body growth and the production of red blood cells. Found in milk, yogurt, cheese, whole and enriched grains, and cereals.

Thiamine (vitamin B1): Helps the body cells change carbohydrates into energy. Found in soy milk and watermelon.

Updated: April 21, 2020 02:24 PM

See the rest here:
How to make sure you are getting enough vitamins: foods, supplements and everything you need to know - The National

Read More...

Stem Cells From Fat Cells – CBS News

Saturday, April 18th, 2020

That spare tire around your waist could have some positive uses after all.

Researchers at UCLA and the University of Pittsburgh have isolated stem cells from fat sucked out of liposuction patients, a breakthrough that could lead to cures for a variety of illnesses.

Stem cells are those cells that haven't been "switched on" yet and have the potential to become almost any kind of tissue, reports CBS News Correspondent Vince Gonzales. Dr. Marc Hedrick, the lead scientist on the project, found that human fat was full of them.

The finding could allow for a more plentiful supply of the cells, paving the way for more medical research. Until now, there has been a scarcity of human stem cells for testing due to the medical and ethical controversy surrounding collection methods.

"Fat is perhaps the ideal source," said Dr. Hedrick. "There's plenty of it. It's easy and inexpensive to obtain. It even has a secondary cosmetic benefit. These cells already have the genetic information to become fat cells or bone cells or muscle cells or cartilage cells. The information's there."

"We don't yet know the limits for stem cells found in fat. So far, we have seen promising results with all of the tissue types we have examined," said Dr. Adam J. Katz, a member of the research team from the University of Pittsburgh School of Medicine. "This discovery could potentially obviate the need for using fetal tissue," a practice opposed by many.

Researchers say that stem cells have the potential to grow new heart muscles for people with cardiac disease and generate new nerve tissue for those with Parkinson's and Alzheimer's diseases. There is even hope for those suffering from spinal cord injuries.

"We hope one day to be able to remove diseased tissue or organs, harvest stem cells and replace the lost tissues on the same day during the same operation," said Hedrick. "There is potential for regenerating a lot of different tissues, perhaps some day solid organs, glands, nerves or brain tissue."

Fat is not the only potential source of adult stem cells. Dr. Ira Black of the Robert Wood Johnson Medical School took stem cells from bone marrow and turned them into nerve cells a possible therapy for spinal injuries and neurological diseases like Alzheimers. "The ultimate goal is to determine if these cells will be useful to replace damaged and dying cells in these diseases and hasten recovery of function."

Encouraging as the latest results with adult stem cells are, some researchers believe they will never match the healing potential of the other, controversial, source of stem cells fetal tissue.

The study, published in the April issue of Tissue Engineering, had researchers take the fat and fluid drained from the hips, buttock and stomachs of liposuction patients.

The material was then washed, purified and treated with an enzyme to break down the matrix holding he cells together and compared to stem cells from bone marrow.

Scientists found that a half-pound of the fatty substance yielded as many as 50 million to 100 million undifferentiated stem-like cells.

Experiments were underway to see if the cells could be used to grow human bone and fat tissue in mice.

But with fetal tissue drawing fire and with an estimated thirteen thousand liposuctions done every week in this country, the fat Americans love to complain about may be a stem cell researcher's best hope.

MMI Viacom Internet Services Inc. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. The Associated Press and Reuters Limited and contributed to this report

Visit link:
Stem Cells From Fat Cells - CBS News

Read More...

Dissecting the FDA’s big, fat stem cell dilemma – The Niche

Saturday, April 18th, 2020

Are fat/adipose stem cells a drug or not?

If yes, what does the FDA do about the hundreds of clinics currently marketing them without approval?

If not, then how does the agency reconcile that with its past statements and even words this year under new Commissioner Scott Gottlieb indicating that the cells are a drug?

Under Gottliebs leadership, the FDArecently took decisive action in two cases related to the use of fat stem cells. There was a raid here in California (StemImmune and California Stem Cell Treatment Center, working in collaboration on an anti-cancer approach drew FDA action on a stem cell-vaccine combo drug product) and a strongly worded warning letter to a clinic in Florida, US Stem Cell Clinic, Inc., which is part of the publicly-traded company US Stem Cell, Inc. ($USRM). Gottlieb also issued a very bold, broader public statement on stem cell clinics, indicating the FDA is very active on oversight of this commercial area.

These developments are encouraging to me in the sense that the FDA now both appears to be more active and clearer in its statements. It is addressing a growing stem cell clinic industry that markets what seem to be unapproved biological drugs without any FDA approval. The clinics also most often lack rigorous data from properly controlled studies to back up what they are selling.

In contrast in the recent past the FDA and its CBER branch, the one specifically tasked with regulating biologics like stem cells, hadnt seemed to be keeping up with the growing stem cell clinic industry. In the past couple years under Obama, the FDA and CBER took near zero apparent action on an industry built selling stem cells without FDA approval and one proliferating at a rapid pace. Now the agency under the new administration seems to be signaling a major change in course on stem cell clinics and a willingness to be bold.

For example, in that warning letter to US Stem Cell Clinic, the FDA indicated unambiguously that a fat stem cell product (similar or identical to that used by many clinics) can be a biological drug that businesses cannot use on patients without prior FDA approval and proper licensing such as a BLA. Presumably this is not a one-time kind of statement about fat stem cells being drugs given consistentpast FDA draft guidance.

Where does the FDA go from here?

If the agency wants to be consistent doesnt it need to do something related to the hundreds of other clinics selling fat stem cell products for a whole medical dictionarys worth of health problems? On the other hand, does the FDA have the will and the resources to take such large-scale action? Does anyone recall the agency ever taking action on hundreds of businesses at once in any field of foods or drugs? Even scores or dozens?

Lets say for the moment that the FDA wants to be consistent on fat stem cell and other stem cell products that are drugs and doesnt want a huge number of businesses marketing what it views as unapproved drug products, which undermines the agencys credibility. If so, does it need to inspect every one of those businesses first, issue hundreds of 483 inspection reports, and then potentially draft and issue an equally large number of warning letters? Or can it just issue the potentially hundreds of warning letters without individual inspections, perhaps based on marketing? Each of these scenarios seems relatively unlikely. Also, my understanding is that many if not most warning letters must get cleared by FDA attorneys too before being issued. Overall, this would be a colossal undertaking.

If the FDA cannot do that, does it instead issue a smaller number of letters (warning or untitled) to a smaller number (perhaps 8-12) stem cell clinics, rather than hundreds, picking the specific businesses that it views as the highest risk? If it takes that course of action, do the tons of other clinics take the hint and stop being non-compliant? Or do they instead just keep doing business as usual and hope that being just one lost in a crowd of hundreds of businesses means the FDA wont take any further steps specifically with them?

In yet another non-mutually exclusive scenario the FDA doesnt take dramatically more concrete action, but in one of the expected upcoming policy/guidance statements it sends a strong message. For instance, in this scenario perhaps the agency announces unambiguously that fat stem cell products cannot be marketed without approval (perhaps with one or more potentially new exceptions such as for breast reconstruction) and in this way it essentially indirectly signals to the large number of businesses to whom this applies to collectively stop marketing unapproved stem cell drugs. Would such a blanket statement be effective without much action or would the stem cell clinicindustry instead just continue to grow fatter at the expense of the bank accounts and potential health of consumers?

Finally, the FDA could back off on the notion of widely classifying adipose stem cells as biological drugs, leaving the big clinic industry largely free to continue business as usual when it comes to adipose stem cell marketing. While this is formally possible, again the recent words and actions from the FDA make it relatively unlikely.What about amniotic stem cell clinics and those businesses marketing bone marrow stem cell treatments that are drugs (e.g. via non-homologous use)?

I asked Patricia Zettler, Associate Professor at Georgia State University College of Law and a former FDA associate chief counsel about the different scenarios for what might happen next with fat stem cell and potentially other noncompliant stem cell commercial outfits. She is one of the most knowledgeable people I know about FDA matters on biologics. Heres what she said:

As you point out, the FDA almost certainlydoes not have the resources to immediately inspect and issue warning letters to the hundreds of stem cell clinics that may be illegally marketing therapies. But the hope, I think, would be that sendingwarning letters tosomemay bring both the recipientsinto compliance as well as detersomeothers from marketing illegal therapies.

Another possibility, I suppose, is sending letters that are not warning letters but that say something like it appears that the stem cell therapy that you are marketing is an unapproved drug;if you believe that approval is not required, please provide us with the basis for that determination. FDA did something similar with some DTC genetic testing companies back in 2010. This might be a way for the agency to get more information about what products are being offered while at the same time signaling to stem cell clinics that they are at risk of a warning letter or other enforcement action if they do not come into compliance.

These make good sense to me as possible developments to come.

Several law firms are keeping a close watch on this fat stem cell FDA situation as well. You can see one example here.

Its not entirely clear how the FDA will approach the stem cell clinic industry overall or the adipose segment, but there is an expectation in the wider community of more FDA action and clearer guidances to come soon.

Related

Go here to read the rest:
Dissecting the FDA's big, fat stem cell dilemma - The Niche

Read More...

Stem cell activity linked to lifestyle – Harvard Magazine

Saturday, April 18th, 2020

Sleep, diet, exercise, and stress: these are factors known to change a persons risk of developing numerous non-communicable diseases. Such lifestyle impacts on healthbeneficial or harmfulexert much of their influence via inflammation. About 10 years ago, Matthias Nahrendorf began wondering just how inflammation and lifestyle might be linked biologically, and started thinking about how to pinpoint the mechanism in the cardinal case of cardiovascular disease.

A persons level of inflammation can easily be measured with a simple white blood cell test. White blood cells fight off bacterial invasions and repair damaged tissues, but they can also damage healthy tissue when they become too abundant. You can find them in atherosclerotic plaques, and you can find them in acute infarcts, says Nahrendorf, a professor of radiology who conducts high-resolution imaging research at Massachusetts General Hospital. You can find them in failing hearts and the brain, where they increase the risk of stroke.

By linking exercise to reduced white blood cell production, Nahrendorf shows how a lifestyle factor can modulate cardiovascular risk.

When Nahrendorf learned that the most potent, toxic, and pro-inflammatory white blood cells live only a few hours, or at most a day, he immediately realized that the paramount questionsgiven that they die off quickly yet remain abundant in the bloodare, where and why are they produced? What is their source? Perhaps, he hypothesized, lifestyle factors regulate hematopoiesis (blood production).

To test this idea, he decided to study the effects of exercise on the production of these leukocytes in healthy mice. First, though, he consulted the scientific literature on exercise in mice. Previous researchers, he learned, had found that exercise increases production of inflammatory immune cellswhich I thought was counterintuitive, Nahrendorf recalls. When he looked more carefully, he discovered that the type of exercise used in the studies was forced and thus possibly stressful because it was induced by electric shocks. He therefore decided to test only voluntary exercise. He and his colleagues put a wheel in each mouses cage, so the animals could choose to run if they were interested.

The mice never ran during the day. That is when they rest, Nahrendorf explains. But in the dark, they ran a lot, averaging six to seven miles every night. After three weeks, the exercising mice had measurably lower levels of circulating white blood cells. Exercise, he found, had pushed their blood stem cells (cells that can produce all the different types of blood cells) into a state of quiescence: a kind of dormancy in which they generate fewer pro-inflammatory white blood cells and platelets, without decreasing the number of oxygen-carrying red blood cells. Soon the exercising mice had fewer circulating white blood cells than their sedentary counterparts, dampening inflammationan effect that persisted for weeks.

The local signals within bone marrow that induce quiescence in blood stem cells were already well known, but the fact that exercise could trigger them was not. Nahrendorf next wanted to learn the identity of the trigger linking exercise to blood stem cell quiescence. Further investigation revealed that the only receptors with enhanced activity in the bone marrow niche where most blood stem cells exist were binding to a well-known hormone called leptin; it is produced by fat cells and regulates hunger.

Leptin is like the fuel gauge in a car. When the tank is fullmeaning energy (and food) are abundantleptin levels run high. As exercise uses up the gas in the tank, this lowers leptin levels, which signal that reserves are running low, thereby inducing hunger and the urge to eat in order to replenish depleted energy stores. Nahrendorf and his co-authors speculate in their 2019 Nature Medicine paper that leptins role in regulating energetically costly hematopoiesis may have evolved to produce blood cells only when whole body energy was abundantnot when people are exerting themselves. Contemporary sedentary behavior, they continue, which increases leptin and consequently hematopoiesis, may have rendered this adaptation a risk factor for cardiovascular disease (CVD) and perhaps also for other diseases with inflammatory components.

But with fewer circulating immune cells, would exercising mice be more vulnerable to infection? Nahrendorf challenged them with a protocol designed to induce infection in the blood, and found just the opposite: exercising mice had a more robust immune response, as semi-dormant blood stem cells swiftly sprang into activity and produced infection-fighting leukocytes, improving survival of the active mice as compared to those with no running wheels in their cages. Next, they investigated whether exercise would help mice with established atherosclerosis, and found that exercise was not only protective, it also reduced the size of existing plaques in the aorta.

Whether these associations would hold up in humans remained an open question. For answers, Nahrendorf turned to a study known as CANTOS, which had measured levels of inflammation in 4,892 patients who suffered heart attacks (see Raw and Red Hot, May-June 2019, page 46). When he approached the studys co-authors, Mallinckrodt professor of medicine Peter Libby and Braunwald professor of medicine Paul Ridker, he learned, serendipitously, not only that they possessed self-reported exercise levels for the participants, but also that they had tested leptin levels as well. They analyzed their raw data and found the same relationship among exercise, leptin, and leukocytes as in the mice. Data from a second human study cemented the result.

By identifying a previously unknown molecular mechanism linking voluntary exercise to reduced white blood cell production, Nahrendorf and his colleagues have highlighted how a lifestyle factor can modulate cardiovascular risk. Their discovery, the researchers hope, will point the way to wider adoption of healthy exercise regimens, and health-enhancing anti-inflammatory drugs.

Go here to read the rest:
Stem cell activity linked to lifestyle - Harvard Magazine

Read More...

Stem Cell Therapy: A Promising Treatment for COVID-19? – Technology Networks

Saturday, April 18th, 2020

Stem cell therapy is making its way into COVID-19 treatment. Its use seems to be particularly efficient in the case of severely ill patients, as demonstrated by a study conducted at the Beijing YouAn Hospital recently published in the peer reviewed journalAging and Disease, and as emerged after the press conference hold by Sun Yanrong, deputy head of the China National Center for Biotechnology Development under the Ministry of Science and Technology.Bioscience Institute a company specializing in stem cell isolation, expansion and cryopreservation reported the results of the Beijing study on the diseases associated with novel coronavirus (SARSCoV-2) infection as they were anticipated before their publication. Now its authors confirm that The intravenous transplantation of MSCs [Mesenchymal Stem Cells] was safe and effective for treatment in patients with COVID-19 pneumonia, especially for the patients in critically severe condition. And according to Sun Yanrong, stem cell treatment has already been used in more than 200 cases in the most affected city in China, Wuhan.Stem cell treatment: how it worksStem cell treatment efficacy lies on the immunomodulatory effect of stem cells. In particular, as emerged from theAging and Diseasestudy, MSCs may help counteract the so-called cytokine storm, an uncontrolled rise of the immune response resulting in the increase of inflammation mediators (cytokines).

During a cytokine storm the immune system goes into overdrive and the patient's tissues and organs can be fatally damaged. Acute respiratory distress syndrome (ARDS) is a common sign of a cytokine storm. In COVID-19 patients it corresponds to the severe oxygen deprivation that requires mechanical ventilation.

Cytokine storm seems to be a good target for severe COVID-19 cases treatment. Nowadays, other drugs, such as tocilizumab, act on this phenomenon. In particular, tocilizumab has already been approved both in China and the USA for the treatment of severe COVID-19 and is used in clinical trials in Europe.Stem cells against COVID-19: beyond ChinaStem cell treatment has already crossed Chinas borders too. A few days before Sun Yanrong pressconference, the US Food and Drug Administration (FDA) opened the way to the compassionate use ofMSCs intravenous infusions in patients with COVID-19 ARDS and a very dismal prognosis.

There are lots of clinical trials that explored, or are planning to explore, immunomodulatory andanti-inflammatory properties of MSCs, Giuseppe Mucci, CEO of Bioscience Institute, highlights.

Cytokines are important mediators of the inflammatory process, and MSCs are believed toregulate their production. In particular, they seem to be involved in the downregulation ofproinflammatory cytokines and in the upregulation of anti-inflammatory cytokines. Their use issafe, and studies in larger cohorts of patients will validate their benefits.

Bioscience Institute is ready to contribute to this validation. We are working on a protocol for aMSCs treatment with stem cells isolated and expanded at our facilities. With our long-standingexperience in the field of stem cells isolation, expansion and cryopreservation, Bioscience Institutelaboratories are among the most advanced in the world.

Compassionate use of MSCs approved by FDA will utilize allogeneic (from a donor) stem cells.However, anyone can build up its own MSCs reserve. They can be easily obtained from severaltissues, but fat is considered the best source ever, Mucci explains. To obtain the huge cellnumbers needed for COVID-19 treatment it is fundamental MSCs expansion. That is why it is notsufficient to rely on a cell bank: only a cell factory like Bioscience Institute is able to guarantee thebanking of a quantity of MSCs useful for such a treatment.

See the article here:
Stem Cell Therapy: A Promising Treatment for COVID-19? - Technology Networks

Read More...

What are the underlying conditions causing more serious illness from coronavirus? – WPBF West Palm Beach

Saturday, April 18th, 2020

We've heard that elderly people and those with underlying health conditions are most at risk if they're infected with coronavirus, but those can seem like really general terms. Who does that include? And why can they face more serious illness?"According to the , some of the underlying conditions that may put you at higher risk include: chronic lung disease and asthma, heart disease and undergoing cancer treatment," said CNN Chief Medical Correspondent Dr. Sanjay Gupta. Anyone with diabetes, kidney failure or liver failure may also be at higher risk.The role of the immune system is to protect against disease or other potentially damaging pathogens. A strong one is needed to help stave off coronavirus infection."Think of it like this," Dr. Gupta suggested. "In your everyday life, you're always fighting off pathogens. Most of the time you don't even realize it. If you have an underlying condition, it makes it more challenging to fight off a virus like this. You may develop a fever, shortness of breath or a cough more easily than someone who doesn't have a preexisting illness."Additionally, there are more specific reasons why each condition has its own vulnerabilities. Here's a guide to underlying conditions affected by coronavirus and why, and how you can protect yourself or an at-risk loved one.Older adultsEight out of 10 deaths reported in the U.S. have been in adults ages 65 and older, according to the CDC. Older adults have also been more likely to require hospitalization and admission to an intensive care unit.Older adults are more likely to have long-term health problems that can increase their risk for infection and serious disease. And, our immune systems usually weaken with age, making it more difficult for people to fight off infections, according to Johns Hopkins Medicine.The quality of our lung tissue also declines over time, becoming more elastic and making respiratory diseases such as COVID-19 of important concern because of the potential for lung damage.Inflammation in older adults can be more intense, leading to organ damage.Those with lung disease, asthma or heart conditionsPeople with chronic airway and lung diseases such as chronic obstructive pulmonary disease, asthma, pulmonary fibrosis and interstitial lung disease can lay the foundations for more severe infection with coronavirus because of the inflammation, scarring and lung damage those conditions cause, Johns Hopkins Medicine reported.COVID-19 affects a person's airway and lungs, but those organs work together to provide the body with oxygen. When the lungs are overburdened with an infection, the heart has to work harder, which exacerbates the challenges of people already living with heart disease.The immunocompromisedAccording to the CDC, many conditions can cause a person to be immunocompromised, including cancer treatment, smoking, bone marrow or organ transplantation and immune deficiencies. Poorly controlled HIV or AIDS and prolonged use of man-made steroid hormones or other immune-weakening medications can also hamper a person's immune function.Cancer can weaken immunity by spreading into the bone marrow, which makes blood cells that help fight infection, according to Cancer Research UK. Cancer prevents bone marrow from making enough blood cells.Some cancer treatments can temporarily weaken the immune system, too. Because cancer treatments such as chemotherapy, cancer drugs, radiotherapy or steroids are targeted toward cancer cells, they can also diminish the number of white blood cells created in the bone marrow.A 2017 study found cigarette smoking can harm the immune system by either causing extreme immune responses to pathogens or rendering the body less effective at fighting disease. This may occur by smoking, negatively altering the cellular and molecular mechanisms responsible for keeping an immune system strong.When a person undergoes a bone marrow transplant using stem cells from a donor, or they receive an organ, a doctor may prescribe medications to prevent graft-versus-host disease and mitigate the immune system's reaction by suppressing its function. After the operation, it takes time for your immune system to be up and running again.HIV and AIDS attack the body's immune system, specifically the body's T cells, which help the immune system fight off infection. When the diseases are untreated, HIV reduces the number of those cells, making the person more likely to contract other infections or infection-related cancer, according to the CDC.Severe obesityPeople with severe obesity, or a body mass index of 40 or higher, are at higher risk of serious disease."Obesity shares with most chronic diseases the presence of an inflammatory component," a 2012 study said. Inflammatory responses were linked between the immune system and body fat. Obesity is known to impair immune function by altering white blood cell count as well as the cells that control immune responses.DiabetesPeople with type 1 or type 2 diabetes face an increased risk of getting really sick with COVID-19, as both cause a blood sugar spike. If blood sugar is poorly managed, viral diseases can be more dangerous as high blood sugar may give viruses a place to thrive, according to Diabetes in Control, a news and information resource for medical professionals.Higher levels of inflammation have been discovered in the bodies of people with diabetes, weakening the immune system and making it more difficult for those affected to stave off sickness in general.Kidney and liver diseaseThe kidneys produce several hormones that affect immune responses. Having kidney disease and failure can weaken your immune system, making it easier for infections to take hold. According to the National Kidney Foundation, doctors and researchers have found that most infections are worse in people with kidney disease.The liver is an integral member of the body's line of defense, helping to regulate the number of white blood cells utilized in immune responses and defend against harmful pathogens. Someone with liver disease is experiencing abnormalities in the function of the immune system, giving rise to more serious illness.Neurodevelopmental conditionsNeurological and neurodevelopmental conditions may also increase the risk of serious COVID-19 for people of any age.These include disorders of the brain, spinal cord, peripheral nerve and muscle such as cerebral palsy, epilepsy, stroke and intellectual disability, according to the CDC. Those with moderate to severe developmental delay, muscular dystrophy or spinal cord injury are also more at-risk.People with neurological conditions may not be more at risk due to solely their condition, but because medications they might take to control their condition could hamper their immune system. However, some neurological conditions, such as Parkinson's, have been recognized to have inflammatory components, which may harm the immune system.Others including muscular dystrophy, multiple sclerosis or amyotrophic lateral sclerosis (ALS) could cause paralysis to the diaphragm, which leaves those affected very at risk for respiratory failure if they were to be sick with COVID-19.Staying safe when you're more at riskIf you see yourself on the list of those at higher risk for severe illness, there are several things you can do to protect yourself. First, make sure you are contact your doctor or doctors about your risk level. Second, be extra vigilant about the recommendations that most people are being asked to follow.Stay home whenever possible and avoid close contact with people, the CDC suggests. Wash your hands often to prevent transferring the virus from a surface to your face, and try to clean and disinfect frequently touched surfaces as often as you can.If you don't have an underlying condition, doing your part by practicing these cautionary measures can help protect not only you, but your loved ones with existing conditions.

We've heard that elderly people and those with underlying health conditions are most at risk if they're infected with coronavirus, but those can seem like really general terms. Who does that include? And why can they face more serious illness?

"According to the [Centers for Disease Control and Prevention], some of the underlying conditions that may put you at higher risk include: chronic lung disease and asthma, heart disease and undergoing cancer treatment," said CNN Chief Medical Correspondent Dr. Sanjay Gupta. Anyone with diabetes, kidney failure or liver failure may also be at higher risk.

The role of the immune system is to protect against disease or other potentially damaging pathogens. A strong one is needed to help stave off coronavirus infection.

"Think of it like this," Dr. Gupta suggested. "In your everyday life, you're always fighting off pathogens. Most of the time you don't even realize it. If you have an underlying condition, it makes it more challenging to fight off a virus like this. You may develop a fever, shortness of breath or a cough more easily than someone who doesn't have a preexisting illness."

Additionally, there are more specific reasons why each condition has its own vulnerabilities. Here's a guide to underlying conditions affected by coronavirus and why, and how you can protect yourself or an at-risk loved one.

Eight out of 10 deaths reported in the U.S. have been in adults ages 65 and older, according to the CDC. Older adults have also been more likely to require hospitalization and admission to an intensive care unit.

Older adults are more likely to have long-term health problems that can increase their risk for infection and serious disease. And, our immune systems usually weaken with age, making it more difficult for people to fight off infections, according to Johns Hopkins Medicine.

The quality of our lung tissue also declines over time, becoming more elastic and making respiratory diseases such as COVID-19 of important concern because of the potential for lung damage.

Inflammation in older adults can be more intense, leading to organ damage.

People with chronic airway and lung diseases such as chronic obstructive pulmonary disease, asthma, pulmonary fibrosis and interstitial lung disease can lay the foundations for more severe infection with coronavirus because of the inflammation, scarring and lung damage those conditions cause, Johns Hopkins Medicine reported.

COVID-19 affects a person's airway and lungs, but those organs work together to provide the body with oxygen. When the lungs are overburdened with an infection, the heart has to work harder, which exacerbates the challenges of people already living with heart disease.

According to the CDC, many conditions can cause a person to be immunocompromised, including cancer treatment, smoking, bone marrow or organ transplantation and immune deficiencies. Poorly controlled HIV or AIDS and prolonged use of man-made steroid hormones or other immune-weakening medications can also hamper a person's immune function.

Cancer can weaken immunity by spreading into the bone marrow, which makes blood cells that help fight infection, according to Cancer Research UK. Cancer prevents bone marrow from making enough blood cells.

Some cancer treatments can temporarily weaken the immune system, too. Because cancer treatments such as chemotherapy, cancer drugs, radiotherapy or steroids are targeted toward cancer cells, they can also diminish the number of white blood cells created in the bone marrow.

A 2017 study found cigarette smoking can harm the immune system by either causing extreme immune responses to pathogens or rendering the body less effective at fighting disease. This may occur by smoking, negatively altering the cellular and molecular mechanisms responsible for keeping an immune system strong.

When a person undergoes a bone marrow transplant using stem cells from a donor, or they receive an organ, a doctor may prescribe medications to prevent graft-versus-host disease and mitigate the immune system's reaction by suppressing its function. After the operation, it takes time for your immune system to be up and running again.

HIV and AIDS attack the body's immune system, specifically the body's T cells, which help the immune system fight off infection. When the diseases are untreated, HIV reduces the number of those cells, making the person more likely to contract other infections or infection-related cancer, according to the CDC.

People with severe obesity, or a body mass index of 40 or higher, are at higher risk of serious disease.

"Obesity shares with most chronic diseases the presence of an inflammatory component," a 2012 study said. Inflammatory responses were linked between the immune system and body fat. Obesity is known to impair immune function by altering white blood cell count as well as the cells that control immune responses.

People with type 1 or type 2 diabetes face an increased risk of getting really sick with COVID-19, as both cause a blood sugar spike. If blood sugar is poorly managed, viral diseases can be more dangerous as high blood sugar may give viruses a place to thrive, according to Diabetes in Control, a news and information resource for medical professionals.

Higher levels of inflammation have been discovered in the bodies of people with diabetes, weakening the immune system and making it more difficult for those affected to stave off sickness in general.

The kidneys produce several hormones that affect immune responses. Having kidney disease and failure can weaken your immune system, making it easier for infections to take hold. According to the National Kidney Foundation, doctors and researchers have found that most infections are worse in people with kidney disease.

The liver is an integral member of the body's line of defense, helping to regulate the number of white blood cells utilized in immune responses and defend against harmful pathogens. Someone with liver disease is experiencing abnormalities in the function of the immune system, giving rise to more serious illness.

Neurological and neurodevelopmental conditions may also increase the risk of serious COVID-19 for people of any age.

These include disorders of the brain, spinal cord, peripheral nerve and muscle such as cerebral palsy, epilepsy, stroke and intellectual disability, according to the CDC. Those with moderate to severe developmental delay, muscular dystrophy or spinal cord injury are also more at-risk.

People with neurological conditions may not be more at risk due to solely their condition, but because medications they might take to control their condition could hamper their immune system. However, some neurological conditions, such as Parkinson's, have been recognized to have inflammatory components, which may harm the immune system.

Others including muscular dystrophy, multiple sclerosis or amyotrophic lateral sclerosis (ALS) could cause paralysis to the diaphragm, which leaves those affected very at risk for respiratory failure if they were to be sick with COVID-19.

If you see yourself on the list of those at higher risk for severe illness, there are several things you can do to protect yourself. First, make sure you are contact your doctor or doctors about your risk level. Second, be extra vigilant about the recommendations that most people are being asked to follow.

Stay home whenever possible and avoid close contact with people, the CDC suggests. Wash your hands often to prevent transferring the virus from a surface to your face, and try to clean and disinfect frequently touched surfaces as often as you can.

If you don't have an underlying condition, doing your part by practicing these cautionary measures can help protect not only you, but your loved ones with existing conditions.

Read the rest here:
What are the underlying conditions causing more serious illness from coronavirus? - WPBF West Palm Beach

Read More...

The Best Face and Body Skin-Care Products for 2020 – Shape Magazine

Saturday, April 18th, 2020

When our panelists were asked which innovation showed the best results, scalp injections of platelet-rich plasma (PRP) for hair growth was at the top of many lists. You get significant benefits with very little downside, Dr. Schultz says. First, your blood is drawn and spun in a centrifuge to separate the PRP, which is then injected all over your scalp. Using your bloods growth factors to stimulate collagen and follicles lets your own body work its magic, says dermatologist Mona Gohara, M.D.

Another new option is a laser called Lutronic KeraLase ($750 to $1,000 per treatment), which is paired with a synthetic growth factor serum. The device stamps across your scalp, stimulating the area and creating tiny channels in the follicles, where the serum is then applied. It delivers active ingredients where theyre needed, says dermatologist Jeanine Downie, M.D. The serum can contain even more growth factors than a persons own PRP, plus stem cells to help hair growth, she says. Nutrafol for Women (Buy It, $79 $88 for 1 month, nutrafol.com), a supplement brand for hair loss, also garnered multiple mentions from our panel. Ive seen promising results, especially in conjunction with the above treatments, Dr. Downie says.

The rest is here:
The Best Face and Body Skin-Care Products for 2020 - Shape Magazine

Read More...

Global Stem Cell Reconstructive Market- Industry Analysis and Forecast (2020-2027) – Publicist360

Monday, April 6th, 2020

Global Stem Cell Reconstructive Market was valued US$ XX Mn in 2019 and is expected to reach US$ XX Mn by 2027, at a CAGR of 24.5% during a forecast period.

Global Stem Cell Reconstructive Market

Market Dynamics

The Research Report gives an in-depth account of the drivers and restraints in the stem cell reconstructive market. Stem cell reconstructive surgery includes the treatment of injured or dented part of body. Stem cells are undifferentiated biological cells, which divide to produce more stem cells. Growing reconstructive surgeries led by the rising number of limbs elimination and implants and accidents are boosting the growth in the stem cell reconstructive market. Additionally, rising number of aged population, number of patients suffering from chronic diseases, and unceasing development in the technology, these are factors which promoting the growth of the stem cell reconstructive market. Stem cell reconstructive is a procedure containing the use of a patients own adipose tissue to rise the fat volume in the area of reconstruction and therefore helping 3Dimentional reconstruction in patients who have experienced a trauma or in a post-surgical event such as a mastectomy or lumpectomy, brain surgery, or reconstructive surgery as a result of an accident or injury. Stem cell reconstructive surgeries are also used in plastic or cosmetic surgeries as well. Stem cell and regenerative therapies gives many opportunities for development in the practice of medicine and the possibility of an array of novel treatment options for patients experiencing a variety of symptoms and conditions. Stem cell therapy, also recognised as regenerative medicine, promotes the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives.

The common guarantee of all the undifferentiated embryonic stem cells (ESCs), foetal, amniotic, UCB, and adult stem cell types is their indefinite self-renewal capacity and high multilineage differentiation potential that confer them a primitive and dynamic role throughout the developmental process and the lifespan in adult mammal.However, the high expenditure of stem cell reconstructive surgeries and strict regulatory approvals are restraining the market growth.

REQUEST FOR FREE SAMPLE REPORT: https://www.maximizemarketresearch.com/request-sample/54666

Global Stem Cell Reconstructive Market Segment analysis

Based on Cell Type, the embryonic stem cells segment is expected to grow at a CAGR of XX% during the forecast period. Embryonic stem cells (ESCs), derived from the blastocyst stage of early mammalian embryos, are distinguished by their capability to distinguish into any embryonic cell type and by their ability to self-renew. Owing to their plasticity and potentially limitless capacity for self-renewal, embryonic stem cell therapies have been suggested for regenerative medicine and tissue replacement after injury or disease. Additionally, their potential in regenerative medicine, embryonic stem cells provide a possible another source of tissue/organs which serves as a possible solution to the donor shortage dilemma. Researchers have differentiated ESCs into dopamine-producing cells with the hope that these neurons could be used in the treatment of Parkinsons disease. Upsurge occurrence of cardiac and malignant diseases is promoting the segment growth. Rapid developments in this vertical contain protocols for directed differentiation, defined culture systems, demonstration of applications in drug screening, establishment of several disease models, and evaluation of therapeutic potential in treating incurable diseases.

Global Stem Cell Reconstructive Market Regional analysis

The North American region has dominated the market with US$ XX Mn. America accounts for the largest and fastest-growing market of stem cell reconstructive because of the huge patient population and well-built healthcare sector. Americas stem cell reconstructive market is segmented into two major regions such as North America and South America. More than 80% of the market is shared by North America due to the presence of the US and Canada.

Europe accounts for the second-largest market which is followed by the Asia Pacific. Germany and UK account for the major share in the European market due to government support for research and development, well-developed technology and high healthcare expenditure have fuelled the growth of the market. This growing occurrence of cancer and diabetes in America is the main boosting factor for the growth of this market.

The objective of the report is to present a comprehensive analysis of the Global Stem Cell Reconstructive Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Stem Cell Reconstructive Market dynamics, structure by analysing the market segments and projects the Global Stem Cell Reconstructive Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Stem Cell Reconstructive Market make the report investors guide.Scope of the Global Stem Cell Reconstructive Market

DO INQUIRY BEFORE PURCHASING REPORT HERE: https://www.maximizemarketresearch.com/inquiry-before-buying/54666

Global Stem Cell Reconstructive Market, By Sources

Allogeneic Autologouso Bone Marrowo Adipose Tissueo Blood Syngeneic OtherGlobal Stem Cell Reconstructive Market, By Cell Type

Embryonic Stem Cell Adult Stem CellGlobal Stem Cell Reconstructive Market, By Application

Cancer Diabetes Traumatic Skin Defect Severe Burn OtherGlobal Stem Cell Reconstructive Market, By End-User

Hospitals Research Institute OthersGlobal Stem Cell Reconstructive Market, By Regions

North America Europe Asia-Pacific South America Middle East and Africa (MEA)Key Players operating the Global Stem Cell Reconstructive Market

Osiris Therapeutics NuVasives Cytori Therapeutics Takeda (TiGenix) Cynata Celyad Medi-post Anterogen Molmed Baxter Eleveflow Mesoblast Ltd. Micronit Microfluidics TAKARA BIO INC. Tigenix Capricor Therapeutics Astellas Pharma US, Inc. Pfizer Inc. STEMCELL Technologies Inc.

MAJOR TOC OF THE REPORT

Chapter One: Stem Cell Reconstructive Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Stem Cell Reconstructive Market Competition, by Players

Chapter Four: Global Stem Cell Reconstructive Market Size by Regions

Chapter Five: North America Stem Cell Reconstructive Revenue by Countries

Chapter Six: Europe Stem Cell Reconstructive Revenue by Countries

Chapter Seven: Asia-Pacific Stem Cell Reconstructive Revenue by Countries

Chapter Eight: South America Stem Cell Reconstructive Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Stem Cell Reconstructive by Countries

Chapter Ten: Global Stem Cell Reconstructive Market Segment by Type

Chapter Eleven: Global Stem Cell Reconstructive Market Segment by Application

Chapter Twelve: Global Stem Cell Reconstructive Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Stem Cell Reconstructive Market Report at: https://www.maximizemarketresearch.com/market-report/global-stem-cell-reconstructive-market/54666/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website: http://www.maximizemarketresearch.com

Visit link:
Global Stem Cell Reconstructive Market- Industry Analysis and Forecast (2020-2027) - Publicist360

Read More...

The rise of ‘rich woman face’: how to halt the ageing process (for a certain price) – Telegraph.co.uk

Monday, April 6th, 2020

'Let me tell you about the very rich,' wrote F Scott Fitzgerald. 'They are different from you and me.' Above all, in the lengths they will go to acquire, and preserve, perfect skin.

Sheikha Moza bint Nasser, the consort of the former Emir of Qatar, may well be the richest person I've ever met. She certainly has skin like no one else on the planet. She's 61 but looks about 40, with a face that seems to have no visible pores, perhaps because it's sculpted out of alabaster.

Admittedly, she is carefully made-up on a regular basis, so she would have been unlikely to want to attend a recent dinner party of Gwyneth Paltrow's in Beverly Hills, at which guests were banned from wearing any cosmetics at all. Kate Hudson and Demi Moore were among those who gamely took the challenge, the idea of which was to allow the assembled LA A-listers to show off their natural glow.

But they don't, of course, rely wholly on nature for their radiance. Moore's evening beauty routine (pared back to the minimum because, she says, "I like to keep it simple") includes eight separate products, with a total cost of 743.50, from a cleansing elixir to a 355 replenishing facial oil and a rose-quartz facial massager in the shape of a butterfly.

No wonder that, far from being petrified at the thought of the make-up-free dinner, she felt 'full of joy', according to her Instagram posts. Her face wasn't coated in foundation, but it was insulated by a thick layer of cash.

With skincare that promises actually to reverse the visible signs of ageing, beauty brands feel entitled to charge impressive sums. La Prairie has one serum, its Platinum Night Elixir, that sells for over 1,000 for 20ml. It costs about 10 more per gram than solid gold. Imagine if your cat knocked that one off the dressing table.

On the other hand, the scientist who developed it says the peptides and amino acids contained in a single daily drop will leave your skin visibly younger-looking and fresher in two weeks. Users say it feels like wrapping your face in cashmere.

La Prairie Platinum Rare Cellular Night Elixir 20ml, 1,018, Harvey Nichols

I rely on Dr Phillip Levy, a Swiss dermatologist and wound-healing specialist based in Geneva, whose moisturisers and serums are proven to revitalise dermal stem cells to kick-start your skin's own production of collagen. Another doctor - German-born Michael Prager, who operates from a clinic in Wimpole Street - emphasises the rejuvenating effects of combating pollution with an antioxidant cream that fights off free radicals.

Neither of these medical-grade ranges comes cheap, but though Dr Prager's day oil contains pure gold, at 225 for 30ml (drmichaelprager.com), it's not actually as expensive as buying the precious metal itself.

If you're going down the Sheikha Moza route to moneyed perfection with a lavish use of make-up, Gucci Westman is a name to conjure with. This make-up artist, who has worked with Natalie Portman and Nicole Kidman, has her own range, Westman Atelier.

Lip suede in Les Rouges, 75, Westman Atelier (net-a-porter.com)

Yes, the colours are lush but, even better, the brand is 'clean' - beauty-speak for vegan, against animal-testing, paraben-free and so on. Plus, the products moisturise, plump up collagen and soothe as you apply them. Even the mascara conditions your lashes. So what if it costs 58?

Equally impressive is Shiseido's luxury line, Cl de Peau, which does a foundation that's 250 for 27ml, in 13 shades. Again, it's a beauty treatment with SPF and moisturiser as much as a make-up product, and it's what I'll put on if I want anyone to tell me I look glowing.

But, of course, more precious than any cream or blush stick is a little personal attention. Dr Costas Papageorgiou operates out of Harrods and has fairly expensive-looking skin himself. He makes use of a battery of lasers, Botox, fillers and ultrasound, but the key to his success is the consultation that starts off the process.

The Foundation,250, Cl de Peau Beaut (harrods.com)

Seeing your own face in unforgiving 3D on a computer may be a shock, but it certainly helps pinpoint the areas you'd like him to focus on. He's very hot on correcting facial symmetry, which starts out pretty good in babies, but with time and use, the muscles on the face become less symmetrical as bits start to droop or wrinkle. Generally, the more lopsided you are, the more antique you look, and he can address that with filler, Botox and even thread lifts.

But I'm not one for the injectables. It's his Hybrid Energy Lift - a combination of ultrasound, infrared, light and laser - that I really rate (from 6,000 for 120 minutes, facialplasticslondon.com). It, too, stimulates collagen production, but it also gets rid of visible veins and redness, and even reduces big pores. I have had to change the tone of my foundation for a paler one since he did for my (mild) rosacea.

Radical3 Reboot Pro Peel, 89, Dr Levy (editorslist.co.uk)

The key, says Dr Papageorgiou, is to delay and reverse the "ageing cascade". This slow car crash of fine lines around the eyes, sun damage and heavy jowls is all thanks, he says, to "fat atrophy and bone resorption".

But subtlety is all - "A great result is one that shows no signs of intervention"- and nothing, he warns, can really be achieved unless you have a healthy diet, exercise and take vitamins.

Debbie Thomas, at her D.Thomas clinic in London, has a similarly personalised approach. You don't book in for a single treatment, you book for an hour of her expert time, and she'll use a cocktail of lasers, micro-needling and products depending on what you need (475 for a DNA Laser Complete 2 session, dthomas.com).

"I'm afraid,"she says, "traditional facials are not going to transform your skin for more than a few days. You need to upgrade to more advanced treatments if you want long-term results. And those will be more costly."And who can say it's not worth the money?

Sign up for theTelegraphLuxury newsletterfor your weekly dose of exquisite taste and expert opinion.

See more here:
The rise of 'rich woman face': how to halt the ageing process (for a certain price) - Telegraph.co.uk

Read More...

Scientists Have ‘Reset’ The Cellular Age Of Cells Taken From A 114-Year-Old Woman – IFLScience

Friday, March 27th, 2020

For the first time, scientists have reprogrammed cells from a 114-year-old woman into induced pluripotent stem cells (iPS cells), a move which they describe as a significant step toward understanding"the underlying mechanisms of extreme longevity and disease resistance."

iPS cells are adult cells that have been genetically reprogrammed into an embryonic stem cell-like state and are able to give rise to any of the specialized cell types of the body, whether its neurons, blood cells, or heart cells.

Until this new project, researchers werent even certain whether they could create viable iPS cellsfrom someone so elderly, let alone a supercentenarian. Now they have shown it's possible to effectively make these aged cells resemble young pluripotent cells, the researchers believe they might have made a step towards the reversal of cellular aging.

"We set out to answer a big question: Can you reprogram cells this old?" Evan Snyder, stem cell researcher at Sanford Burnham Prebys Medical Discovery Institute in California, said in a statement.

"Now we have shown it can be done, and we have a valuable tool for finding the genes and other factors that slow down the aging process."

Reporting in the journal Biochemical and Biophysical Research Communications, researchers harnessed iPS cells from the blood cells of a 114-year-old woman, a healthy 43-year-old person, and an 8-year-old child with a rare genetic condition characterized by the rapid aging in childhood. These iPS cells were then turned into mesenchymal stem cells, cells that help maintain and repair the body's structural tissues differentiating into bone, cartilage, muscle, or fat cells.

Remarkably, the cells produced from the supercentenarian transformed just as easily as the others. They also noted the supercentenarian-derived stem cells appeared to have reset their telomeres.

Telomeresarethe protective caps on the end of a chromosome. Since they shorten each time a cell copies itself, they also get shorter as we age and eventually stop functioning properly. Thispersistent shortening allows researchers to use telomeres as a kind of aging clock in every cell.Interestingly, the stem cells from the supercentenarian showed no indication of this aging. They had effectively reset the clock on the cells from114 years to zero.

To dive deeper into this discovery, the researchers hope to compare body cells derived from the healthy iPSCs and supercentenarian iPSCs. The researchers could also start to use the supercentenarian cells to understand why certain people have such long lives compared to others.

Why do supercentenarians age so slowly? We are now set to answer that question in a way no one has been able to before, said Snyder.

Read more from the original source:
Scientists Have 'Reset' The Cellular Age Of Cells Taken From A 114-Year-Old Woman - IFLScience

Read More...

Page 5«..4567..1020..»


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick